Clinical Trial Update: Buccal Prochlorperazine Versus Intravenous Prochlorperazine for Migraine Headaches, a RCT [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing buccal prochlorperazine to intravenous prochlorperazine for migraine headaches.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Disorders

Drugs mentioned

• buccal prochlorperazine (prochlorperazine)
• intravenous prochlorperazine (prochlorperazine)

Snippet

Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Conditions: Migraine Disorders | Phase 3 | Status: UNKNOWN